Premium
EVIDENCE FOR THYROIDAL SECRETION OF 3,3′,5′‐TRIIODOTHYRONINE IN MAN AND ITS CONTROL BY TSH
Author(s) -
HOOPER M. J.,
RATCLIFFE J. G.,
RATCLIFFE W. A.,
MARSHALL J.,
YOUNG R. E.,
NGAEI G.,
CLARK D. H.
Publication year - 1978
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1978.tb01503.x
Subject(s) - medicine , endocrinology , euthyroid , microgram , triiodothyronine , thyroid , hormone , reverse triiodothyronine , vein , chemistry , biochemistry , in vitro
SUMMARY Thyroidal secretion of 3,3′,5′‐triiodothyronine (reverse T3, rT3) and its control by TSH was assessed by measuring (1) arterio‐venous hormone gradients in patients undergoing surgery, (2) changes of hormone concentrations after induction of anaesthesia, and (3) changes induced by TRH administration. In ten patients in whom thyroid activity was under TSH control (parathyroidectomy and non‐toxic goitre) increased thyroid vein/carotid artery ratios (TV/CA) for rT3 (mean TV/CA ratio 2.53) were found when compared to six patients with non‐toxic goitre on suppressive doses of T4 (mean TV/CA ratio, 1.27) ( P > 0.05). The mean calculated operative secretion rate of rT3 was 12.5 μg/day but only 2.4 μg/day in patients receiving T4. In thirteen patients undergoing elective surgery induction of anaesthesia significantly increased rT3 levels. In nine euthyroid adults intravenous TRH (200 μg) increased peripheral venous rT3 levels between 3 h ( P > 0.005) and 8 h ( P > 0.05) after the injection. It is concluded that significant amounts of rT3 are secreted by the thyroid gland at operation and this is, in part, under TSH control.